January 30, 2019
A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)
Read More
January 30, 2019
Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer
Read More
January 30, 2019
Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer
Read More
January 30, 2019
Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
Read More
X